Prospective observational study to describe routine use of XGEVAâ for prevention of skeletal related events (SREs) in subjects with bone metastases from prostate carcinoma in Bulgaria (20180095)

First published 19/12/2018

Last updated 17/04/2023

EU PAS number:

EUPAS26983

Study

Finalised

Documents

Study protocol

Initial protocol

20180095_01.02.06 Public Redacted Protocol Ver 1.0 2018-10-24 English

English (255.48 KB - PDF) View document

Study results

20180095 01.47.01.01 Observational Research Study Report Published Report_Redacted

English (492.48 KB - PDF) View document

Study report

Other information

Secondary tabs